An
article from Frank Chiropractic reported that drug research is
full of conflicts of interest that threaten drug safety, using GAP’s 2009
report, The ABC’s of Drug Safety, as its main evidence. One conflict, for
example, is that while drug companies continue to grow, the FDA continues to
experience cutbacks, thus threatening regulation and oversight.
A
physician and a community hospital in Minnesota agreed
to pay almost $850,000 after another doctor blew the whistle on
fraudulently billing of Medicare for "unreasonable and unnecessary"
hospitalizations. Under a federal law, the whistleblower received
$203,150.
In
other news, the New York Times featured an editorial by two members of the 9/11
Commission arguing that the government
should examine the entire intelligence and airline safety system to
determine if the failures that lead to 9/11 and the failed Christmas Day terror
attempt are endemic or fixable. Obviously, despite the commission’s
recommendations, major lapses are still apparent.

Recent Comments